- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.17 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
- 2 x 7UI: 8-(4-bromophenyl)-6-(4-methoxyphenyl)-2-[2,2,2-tris(fluoranyl)ethylamino]pyrido[4,3-d]pyrimidin-7-ol(Non-covalent)
7UI.2: 26 residues within 4Å:- Chain A: F.19, L.20, F.21, Q.191, D.192, R.193, G.194, A.195, V.196, G.274, W.275, G.276, R.314
- Chain B: F.140, A.277, L.316, V.317, Q.318, S.332, I.333, F.334, E.343
- Ligands: EDO.3, MG.11, MG.12, MG.24
21 PLIP interactions:13 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:F.21, A:Q.191, A:Q.191, A:V.196, A:W.275, A:W.275, B:L.316, B:F.334
- Hydrogen bonds: A:D.192, A:G.194, A:R.314, A:R.314, B:S.332
- pi-Stacking: A:F.19, A:F.19, B:F.334, B:F.334
- Halogen bonds: A:G.274, B:S.332
- Water bridges: B:S.332, B:S.332
7UI.14: 26 residues within 4Å:- Chain A: F.140, A.277, L.316, V.317, Q.318, S.332, I.333, F.334, E.343
- Chain B: F.19, L.20, F.21, Q.191, D.192, R.193, G.194, A.195, V.196, G.274, W.275, G.276, R.314
- Ligands: MG.12, EDO.15, MG.23, MG.24
21 PLIP interactions:8 interactions with chain A, 13 interactions with chain B- Hydrophobic interactions: A:L.316, A:F.334, B:F.21, B:Q.191, B:Q.191, B:V.196, B:W.275, B:W.275
- Hydrogen bonds: A:S.332, B:D.192, B:G.194, B:R.314, B:R.314
- Water bridges: A:S.332, A:S.332
- pi-Stacking: A:F.334, A:F.334, B:F.19, B:F.19
- Halogen bonds: A:S.332, B:G.274
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: G.194, R.314, F.334, Y.336
- Chain B: F.334
- Ligands: 7UI.2, EDO.15
No protein-ligand interaction detected (PLIP)EDO.4: 5 residues within 4Å:- Chain A: K.229, A.230, V.231, V.232, P.233
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:A.230
EDO.5: 5 residues within 4Å:- Chain A: H.159, K.160, A.163, Y.378, R.383
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.383
EDO.6: 5 residues within 4Å:- Chain A: V.83, E.86, A.87, H.90, Q.373
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.86, A:Q.373
- Water bridges: A:A.87
EDO.15: 7 residues within 4Å:- Chain A: F.334
- Chain B: G.194, R.314, F.334, Y.336
- Ligands: EDO.3, 7UI.14
No protein-ligand interaction detected (PLIP)EDO.16: 5 residues within 4Å:- Chain B: K.229, A.230, V.231, V.232, P.233
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:A.230
EDO.17: 5 residues within 4Å:- Chain B: H.159, K.160, A.163, Y.378, R.383
1 PLIP interactions:1 interactions with chain B- Water bridges: B:R.383
EDO.18: 5 residues within 4Å:- Chain B: V.83, E.86, A.87, H.90, Q.373
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.86, B:Q.373
- Water bridges: B:A.87
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 4 residues within 4Å:- Chain A: E.112, Q.113
- Chain B: T.63, Q.257
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:E.112, B:T.63, B:Q.257
GOL.19: 4 residues within 4Å:- Chain A: T.63, Q.257
- Chain B: E.112, Q.113
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:T.63, A:Q.257, B:E.112
- 2 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
1PE.8: 7 residues within 4Å:- Chain A: Q.81, K.82, R.85, E.86, K.89, Y.102, K.103
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Q.81
- Hydrogen bonds: A:E.86, A:K.89
1PE.20: 7 residues within 4Å:- Chain B: Q.81, K.82, R.85, E.86, K.89, Y.102, K.103
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:Q.81
- Hydrogen bonds: B:E.86, B:K.89
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.10: 4 residues within 4Å:- Chain B: A.56, K.286, K.290
- Ligands: SAM.1
No protein-ligand interaction detected (PLIP)MG.11: 6 residues within 4Å:- Chain A: Y.142, W.275, G.276, R.314, Y.336
- Ligands: 7UI.2
No protein-ligand interaction detected (PLIP)MG.12: 5 residues within 4Å:- Chain A: Y.336
- Chain B: Y.336
- Ligands: 7UI.2, 7UI.14, MG.24
No protein-ligand interaction detected (PLIP)MG.22: 4 residues within 4Å:- Chain A: A.56, K.286, K.290
- Ligands: SAM.13
No protein-ligand interaction detected (PLIP)MG.23: 6 residues within 4Å:- Chain B: Y.142, W.275, G.276, R.314, Y.336
- Ligands: 7UI.14
No protein-ligand interaction detected (PLIP)MG.24: 5 residues within 4Å:- Chain A: Y.336
- Chain B: Y.336
- Ligands: 7UI.2, MG.12, 7UI.14
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, M. et al., Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J.Med.Chem. (2022)
- Release Date
- 2022-03-23
- Peptides
- S-adenosylmethionine synthase isoform type-2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.17 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
- 2 x 7UI: 8-(4-bromophenyl)-6-(4-methoxyphenyl)-2-[2,2,2-tris(fluoranyl)ethylamino]pyrido[4,3-d]pyrimidin-7-ol(Non-covalent)
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 2 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, M. et al., Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J.Med.Chem. (2022)
- Release Date
- 2022-03-23
- Peptides
- S-adenosylmethionine synthase isoform type-2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A